Antares Pharma, Inc. (NASDAQ:ATRS)
CAPS Rating:
The Company develops, produces and markets pharmaceutical delivery products, including transdermal gels, oral fast melting tablets and reusable needle-free and disposable mini-needle injector systems.
RSS Headlines
Fool UK
Recs
I really feel like this is a company worth while to everyone in times of uncertainty. Though there is some volatility associated with the company related to the overall health of the market, with a balance sheet that has NO debt, and several items in development and out already, not to mention a recent partnership with Pfiser, this company really seems like it is an absolute STEAL right now below $5 a share. Will only go up.